Simulect
OVERDOSE
A maximum tolerated dose of Simulect® has not been determined in patients. During the course of clinical studies, Simulect® has been administered to adult renal transplantation patients in single doses of up to 60 mg, or in divided doses over 3-5 days of up to 120 mg, without any associated serious adverse events. There has been one spontaneous report of a pediatric renal transplantation patient who received a single 20-mg dose (2.3 mg/kg) without adverse events.
CONTRAINDICATIONS
Simulect® is contraindicated in patients with known hypersensitivity to basiliximab or any other component of the formulation. See composition of Simulect® under DESCRIPTION.
Generic Name: Basiliximab
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Heart Health
Get the latest treatment options.
Health Extras
At Risk for Heart Disease?
Thanks to new technology, in just 15 seconds you can tell if you’re at risk for heart disease. Learn about this new tool. See more WebMD Videos »
Simulect
Health Resources
Updated & New
RxList does not provide medical advice, diagnosis or treatment.